Anaphylaxis primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Anaphylaxis}} {{CMG}} ==Overview== ==Primary Prevention== The greatest success with prevention of anaphylaxis has been the use of allergy injections to prevent...") |
|||
| (23 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anaphylaxis}} | {{Anaphylaxis}} | ||
{{CMG}}, {{AE}} [[User:Dushka|Dushka Riaz, MD]] | |||
==Overview== | |||
== | Prevention is very important in [[anaphylaxis]] to protect patients against repeated episodes. Patients should see an [[allergist]] to identify their [[Allergen|allergens]] so they can avoid being triggered by them. <ref name="pmid28800865">{{cite journal| author=LoVerde D, Iweala OI, Eginli A, Krishnaswamy G| title=Anaphylaxis. | journal=Chest | year= 2018 | volume= 153 | issue= 2 | pages= 528-543 | pmid=28800865 | doi=10.1016/j.chest.2017.07.033 | pmc=6026262 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28800865 }} </ref> | ||
==Primary Prevention== | ==Primary Prevention== | ||
Prevention of [[anaphylaxis]] is by the patient becoming aware of their triggers and avoiding it. It is also important to manage [[Comorbidity|comorbid]] conditions such as [[asthma]], [[cardiovascular disease]], and [[mastocytosis]] which increase the severity of [[anaphylaxis]]. Patients should be aware that taking [[beta blockers]] can block the response to administration of [[epinephrine]]. Compliance among patience to carry an [[epinephrine]] auto injection should be encouraged. <ref name="pmid26918144">{{cite journal| author=Irani AM, Akl EG| title=Management and Prevention of Anaphylaxis. | journal=F1000Res | year= 2015 | volume= 4 | issue= | pages= | pmid=26918144 | doi=10.12688/f1000research.7181.1 | pmc=4754021 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26918144 }} </ref> In the case of children, [[food]] is the most common culprit. Therefore, mothers should be careful in introducing new foods to their children. <ref name="pmidhttps://doi.org/10.1542/peds.2016-4006">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1542/peds.2016-4006 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> In case of an active episode, [[patients]] and healthcare providers should prioritize removing the patient from the potential [[allergen]] immediately. Once the episode has resolved patients should be referred to an [[allergist]] to identify possible causes to avoid them in the future. <ref name="pmid20176258">{{cite journal| author=Simons FE| title=Anaphylaxis. | journal=J Allergy Clin Immunol | year= 2010 | volume= 125 | issue= 2 Suppl 2 | pages= S161-81 | pmid=20176258 | doi=10.1016/j.jaci.2009.12.981 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20176258 }} </ref> <ref name="pmid21377030">{{cite journal| author=Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J | display-authors=etal| title=World Allergy Organization anaphylaxis guidelines: summary. | journal=J Allergy Clin Immunol | year= 2011 | volume= 127 | issue= 3 | pages= 587-93.e1-22 | pmid=21377030 | doi=10.1016/j.jaci.2011.01.038 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21377030 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Needs overview]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Cardiology]] | |||
[[Category:Allergology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 21:54, 14 April 2021
|
Anaphylaxis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anaphylaxis primary prevention On the Web |
|
American Roentgen Ray Society Images of Anaphylaxis primary prevention |
|
Risk calculators and risk factors for Anaphylaxis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
Prevention is very important in anaphylaxis to protect patients against repeated episodes. Patients should see an allergist to identify their allergens so they can avoid being triggered by them. [1]
Primary Prevention
Prevention of anaphylaxis is by the patient becoming aware of their triggers and avoiding it. It is also important to manage comorbid conditions such as asthma, cardiovascular disease, and mastocytosis which increase the severity of anaphylaxis. Patients should be aware that taking beta blockers can block the response to administration of epinephrine. Compliance among patience to carry an epinephrine auto injection should be encouraged. [2] In the case of children, food is the most common culprit. Therefore, mothers should be careful in introducing new foods to their children. [3] In case of an active episode, patients and healthcare providers should prioritize removing the patient from the potential allergen immediately. Once the episode has resolved patients should be referred to an allergist to identify possible causes to avoid them in the future. [4] [5]
References
- ↑ LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). "Anaphylaxis". Chest. 153 (2): 528–543. doi:10.1016/j.chest.2017.07.033. PMC 6026262. PMID 28800865.
- ↑ Irani AM, Akl EG (2015). "Management and Prevention of Anaphylaxis". F1000Res. 4. doi:10.12688/f1000research.7181.1. PMC 4754021. PMID 26918144.
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1542/peds.2016-4006 Check
|pmid=value (help). - ↑ Simons FE (2010). "Anaphylaxis". J Allergy Clin Immunol. 125 (2 Suppl 2): S161–81. doi:10.1016/j.jaci.2009.12.981. PMID 20176258.
- ↑ Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J; et al. (2011). "World Allergy Organization anaphylaxis guidelines: summary". J Allergy Clin Immunol. 127 (3): 587-93.e1-22. doi:10.1016/j.jaci.2011.01.038. PMID 21377030.